机构:
Univ Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U1000,Ctr Enseignement Rech & Traitmen, F-94800 Villejuif, FranceUniv Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U1000,Ctr Enseignement Rech & Traitmen, F-94800 Villejuif, France
Karila, Laurent
[1
]
Zarmdini, Rim
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U669,Ctr Enseignement Rech & Traitment, F-94800 Villejuif, FranceUniv Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U1000,Ctr Enseignement Rech & Traitmen, F-94800 Villejuif, France
Zarmdini, Rim
[2
]
Petit, Aymeric
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 07, Hop Bichat, AP HP, Serv Psychiat & Addictol, Paris, FranceUniv Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U1000,Ctr Enseignement Rech & Traitmen, F-94800 Villejuif, France
Petit, Aymeric
[3
]
Lafaye, Genevieve
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U669,Ctr Enseignement Rech & Traitment, F-94800 Villejuif, FranceUniv Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U1000,Ctr Enseignement Rech & Traitmen, F-94800 Villejuif, France
Lafaye, Genevieve
[2
]
Lowenstein, William
论文数: 0引用数: 0
h-index: 0
机构:
SOS Addict, F-75016 Paris, FranceUniv Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U1000,Ctr Enseignement Rech & Traitmen, F-94800 Villejuif, France
Lowenstein, William
[4
]
Reynaud, Michel
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U669,Ctr Enseignement Rech & Traitment, F-94800 Villejuif, FranceUniv Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U1000,Ctr Enseignement Rech & Traitmen, F-94800 Villejuif, France
Reynaud, Michel
[2
]
机构:
[1] Univ Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U1000,Ctr Enseignement Rech & Traitmen, F-94800 Villejuif, France
[2] Univ Paris 11, Hop Univ Paul Brousse, AP HP, CEA Inserm U669,Ctr Enseignement Rech & Traitment, F-94800 Villejuif, France
[3] Univ Paris 07, Hop Bichat, AP HP, Serv Psychiat & Addictol, Paris, France
[4] SOS Addict, F-75016 Paris, France
来源:
PRESSE MEDICALE
|
2014年
/
43卷
/
01期
关键词:
DRUG-USE;
DEPENDENCE;
RELIABILITY;
VALIDITY;
D O I:
10.1016/j.lpm.2013.01.069
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Cocaine remains the second most commonly used illicit drug worldwide after cannabis. Observed levels of cocaine use among countries considerably vary. An increased cocaine use is recorded in the general European population. Cocaine addiction is a worldwide public health problem, which has somatic, psychiatric, socio-economic and judicial complications. It is a multifactorial disorder variable in its clinical manifestations and heritable. Compared to the general population, there is a high prevalence of somatic and psychiatric disorders among cocaine-dependent patients. There are predictable dose-related effects of pharmacological action of cocaine and effects which are uncommon, unrelated to dose and occur randomly in this population. The number of patients entering drug treatment for primary cocaine use has been increasing in Europe for several years. However, there is no specific pharmacotherapy with established efficacy for the treatment of cocaine addiction, nor is any medication approved by regulatory authorities for such treatment. Recent controlled clinical studies and laboratory studies have highlighted some very promising medications. The perfect therapeutic platform for abstinence initiation and relapse prevention of cocaine addiction is a combination of pharmacological treatments and behavioral treatments. Targeting somatic and psychiatric comorbidity is another way to use pharmacological treatments in addictions.